New anti-inflammatory 4-hydroxyisoflavans from Solanum lyratum

Area of Science:

• Natural Product Chemistry
• Pharmacology
• Medicinal Plant Research

Background:

• Solanum lyratum is a plant with a history of traditional medicinal use.
• Isoflavans are a class of compounds known for diverse biological activities.
• Inflammation is a key factor in many diseases, necessitating the search for novel anti-inflammatory agents.

Purpose of the Study:

• To isolate and characterize new compounds from Solanum lyratum.
• To evaluate the anti-inflammatory potential of isolated compounds.

Main Methods:

• Phytochemical investigation of Solanum lyratum whole plant.
• Structure elucidation using detailed physical data analyses (e.g., NMR, MS).
• In vitro anti-inflammatory assay measuring beta-glucuronidase release from rat polymorphonuclear leukocytes.

Main Results:

• Three new 4-hydroxyisoflavans (lyratin A, B, and C) and one known isoflavan were isolated.
• All four compounds exhibited anti-inflammatory activity.
• Inhibitory ratios of beta-glucuronidase release ranged from 30.3% to 38.6% at 10 microM concentration.

Conclusions:

• Solanum lyratum is a source of novel 4-hydroxyisoflavans.
• The isolated compounds possess significant in vitro anti-inflammatory properties.
• These findings support the ethnobotanical use of Solanum lyratum and suggest potential for developing new anti-inflammatory drugs.